Malaria vaccine development in Europe - preparing for the future

Brussels

Ninety people registered for the workshop, which was held at Louise Centre, Avenue Louise 287, Brussels.  EVI valued your participation and extends heartfelt thanks for your contribution.  We are sure you join EVI in looking forward to witnessing the benefits of the workshop throughout the scientific community.
Outcome published in Vaccine

Background and aim of the workshop:

A great deal of time and effort has been put into the preparation of the 2013 Update of the Malaria Vaccine Technology Roadmap (MVTR) http://www.euvaccine.eu/vaccines-diseases/diseases-poverty/malaria.  In order to ensure that the strategic goals set by the MVTR are achieved, further elaboration of the various priority areas defined in the roadmap is urgently needed.  The aim of the workshop was to bring together key players of the European malaria community to define and prioritise the key activities to be undertaken in the coming years, and to outline Europe’s contribution to the implementation of the roadmap in a global context with the main stakeholders.

A great deal of time and effort has been put into the preparation of the 2013 Update of the Malaria Vaccine Technology Roadmap (MVTR) http://www.euvaccine.eu/vaccines-diseases/diseases-poverty/malaria.  In order to ensure that the strategic goals set by the MVTR are achieved, further elaboration of the various priority areas defined in the roadmap is urgently needed.  The aim of the workshop was to bring together key players of the European malaria community to define and prioritise the key activities to be undertaken in the coming years, and to outline Europe’s contribution to the implementation of the roadmap in a global context with the main stakeholders.

EVI_MDVE-WS-photo-44-group_Final_141128_opt.jpg

Workshop participants

Workshop session topics:

  • Innovation and discovery/Correlate and surrogate of protection
  • Combination vaccines: Multi-stage, Multi-Antigen
  • Clinical aspects of vaccine development/Controlled human malaria infection models
  • Capacity building in GMP manufacturing and clinical trials

The session topics were introduced by a speaker followed by parallel group sessions with reporting of the conclusions to the main meeting.

Scientific organising committee members:

Odile Leroy (European Vaccine Initiative) (chair), Adrian Hill (University of Oxford), Alister Craig (Liverpool School of Tropical Medicine), Chetan Chitnis (Institut Pasteur), Clemens Kocken (Biomedical Primate Research Centre), and Peter Kremsner (University of Tübingen).

Agenda and list of participants

Workshop participants

Workshop session topics:

  • Innovation and discovery/Correlate and surrogate of protection
  • Combination vaccines: Multi-stage, Multi-Antigen
  • Clinical aspects of vaccine development/Controlled human malaria infection models
  • Capacity building in GMP manufacturing and clinical trials

The session topics were introduced by a speaker followed by parallel group sessions with reporting of the conclusions to the main meeting.

Scientific organising committee members:

Odile Leroy (European Vaccine Initiative) (chair), Adrian Hill (University of Oxford), Alister Craig (Liverpool School of Tropical Medicine), Chetan Chitnis (Institut Pasteur), Clemens Kocken (Biomedical Primate Research Centre), and Peter Kremsner (University of Tübingen).

Agenda and list of participants

A great deal of time and effort has been put into the preparation of the 2013 Update of the Malaria Vaccine Technology Roadmap (MVTR) http://www.euvaccine.eu/vaccines-diseases/diseases-poverty/malaria.  In order to ensure that the strategic goals set by the MVTR are achieved, further elaboration of the various priority areas defined in the roadmap is urgently needed.  The aim of the workshop was to bring together key players of the European malaria community to define and prioritise the key activities to be undertaken in the coming years, and to outline Europe’s contribution to the implementation of the roadmap in a global context with the main stakeholders.

Workshop participants

Workshop session topics:

  • Innovation and discovery/Correlate and surrogate of protection
  • Combination vaccines: Multi-stage, Multi-Antigen
  • Clinical aspects of vaccine development/Controlled human malaria infection models
  • Capacity building in GMP manufacturing and clinical trials

The session topics were introduced by a speaker followed by parallel group sessions with reporting of the conclusions to the main meeting.

Scientific organising committee members:

Odile Leroy (European Vaccine Initiative) (chair), Adrian Hill (University of Oxford), Alister Craig (Liverpool School of Tropical Medicine), Chetan Chitnis (Institut Pasteur), Clemens Kocken (Biomedical Primate Research Centre), and Peter Kremsner (University of Tübingen).

Agenda and list of participants